Myocardial protection conferred by ischemic preconditioning occurs in a bimodal time course. The early cardioprotection wanes rapidly and is succeeded by a delayed phase of protection reducing infarct development, myocardial stunning and arrhythmias. This 'second window' of preconditioning may be evident for up to 72 h. The current mechanistic paradigm for delayed preconditioning against infarction invokes roles for several freely-diffusible molecules, generated during the preconditioning period, that act in autocrine and / or paracrine fashion as triggers of cellular adaptation. These include adenosine, nitric oxide, reactive oxygen species and bradykinin. A role for adenosine receptor activation as a proximal molecular mechanism leading to delayed preconditioning against infarction was established in 1994. Pharmacological adenosine receptor blockade during preconditioning abolishes the acquisition of delayed protection, while transient adenosine A or A receptor activation fully recapitulates protection against infarction (but not against stunning or 
. Introduction
2 . Adenosine A agonist-induced delayed protection 1 Early experimental evidence supporting the critical role of adenosine as a trigger of classic ischemic preconditioning came from Liu et al. [19] who showed that adenosine receptor blockade with 8-( p-sulphophenyl)-theophylline (8-SPT) abolished the infarct-limiting effect of preconditioning in rabbit heart. It was subsequently shown that transient adenosine A receptor (but not A receptor) 1 2 activation with selective agonists reproduced the infarctlimiting effect of ischemic preconditioning in the rabbit, rat and dog [20] [21] [22] [23] . Pharmacological evidence also supports a role of adenosine A receptor activation in 3 classic ischemic preconditioning [24] [25] [26] . The recognition of delayed preconditioning occurred at a time when focused on the acquisition of heat shock proteins and antioxidant enzymes in the mechanism of delayed protection following transient oxidative stress. We were aware of factors are generated in myocardium which act as initiators no evidence to suggest that adenosine might regulate the or triggers of both the early and late forms of preconditioninduction or activities of these proteins and we believed ing. In relation to delayed preconditioning, the most that the early and delayed phases of protection were important of these molecular triggers appear to be rapidlytemporally and mechanistically distinct phenomena. A generated 'diffusible mediators': adenosine, bradykinin study was undertaken with the null hypothesis that adenoand NO. Evidence supporting an 'adenosine hypothesis' of sine was not involved as a trigger of delayed preconditiondelayed preconditioning dates from 1994 [9] . Subsequenting [9] . Delayed preconditioning was induced in anesly, the 'nitric oxide (NO) hypothesis' of delayed precondithetised rabbits, using 435-min occlusions of a left tioning was developed and extensively tested [10, 11] . coronary artery branch, each separated by 10-min reperfuMore recent evidence supports the involvement of bradysion periods. During this preconditioning protocol, animals kinin as a trigger of delayed preconditioning, signalling were treated with an intravenous infusion of 8-SPT for 60 through an NO-dependent mechanism [12, 13] . It is posmin or saline. Twenty four hours after this pretreatment, sible that other local paracrine triggers may participate in the animals were subjected to an index coronary artery delayed preconditioning, including opioid peptides, cytoocclusion of 30 min after which infarct size was assessed kines and catecholamines. There is evidence that genewith triphenyltetrazolium chloride (TTC) staining. Isration of intracellular reactive oxygen species, especially chemic preconditioning resulted in a significant limitation the superoxide anion, acts as a trigger of delayed precondiof infarct size compared to sham-operated controls. Howtioning [14, 15] . A relatively unexplored area is the role of ever, adenosine receptor blockade with 8-SPT during the a variety of early biochemical and biophysical alterations preconditioning protocol completely abolished the cardioin the preconditioned myocardium which may act as protective effects observed 24 h later, prompting the regulatory switches of adaptation. These include changes conclusion that adenosine receptor activation during isin oxygen tension, intracellular pH, redox potential, oschemic preconditioning was likely to be an essential motic alterations leading to cell swelling and membrane trigger of the late protective response (see Fig. 2A ). stretch. Together, these various triggers of adaptation
The literature of classic preconditioning at that time initiate a complex signal transduction sequence that insuggested that adenosine induced its acute anti-ischemic cludes the activation of multiple kinases and transcription actions through A receptor activation. In a cognate study, actors. The distinctive time course of delayed precondinon-preconditioned naıve rabbits received a single intioning [16, 17] , its abolition by protein synthesis inhibitors travenous bolus of the highly selective adenosine A 1
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[18] and the association of protection with a number of receptor agonist 2-chloro-N -cyclopentyladenosine inducible gene products together provide compelling evi-(CCPA) or saline vehicle, 24 h prior to index coronary dence of a distal effector mechanism related to the artery occlusion. CCPA has a 10 000-fold selectivity for acquisition of new proteins [6, 7] . The focus of this review adenosine A versus A receptors and a subnanomolar 1 2 is the role of adenosine as a proximal component of the receptor affinity. CCPA was shown to be a relatively delayed preconditioning mechanism.
short-acting compound, with reversal of the hemodynamic 25 -100 mg / kg resulted in progressive reduction of infarct myocardium because the late protection against ischemiasize compared to saline treated animals with the maximum reperfusion injury was also evident in isolated Langenprotection observed at 100 mg / kg (Fig. 2B) .
dorff-perfused rabbit hearts [27] . This observation exThese early experiments described a previously unrecluded any contributory mechanism involving systemic cognised physiological action of adenosine A receptor neurohormonal or blood-borne elements in the delayed 'NO hypothesis' of delayed preconditioning, has stimuemphasised that there is no evidence to suggest that A 3 lated a fundamental advance into the molecular pathways receptor activation forms part of the endogenous pathway of delayed preconditioning and is reviewed more fully in for delayed ischemic preconditioning. Indeed, the receptor this issue by Roberto Bolli (pp. 506-519). The important antagonist 8-SPT used in the original study pointing to question of whether adenosine and NO act as independent adenosine receptor participation in delayed preconditioning triggers arises because some important actions of adeno-
[9] has only weak affinity for A receptors yet it abolished 3 sine A receptor activation in cardiovascular cell types the delayed protection. Although at present it seems likely 1 appear to be mediated by NO generation [28] [29] [30] [31] . In the that endogenous adenosine elicits protection via A re-1 rabbit, Dana et al. [32] found that the NO synthase ceptor activation, definitive proof of A receptor in -3 inhibitor nitro-L-argine methyl ester (L-NAME) adminisvolvement awaits studies of delayed ischemic preconditered prior to an A agonist did not prevent the developtioning in A receptor-knockout mice (with the caveat 1 3 ment of late tolerance to ischemia, suggesting that adenostated previously) and in studies undertaken with reliably sine A receptor activation and NO are independent coselective A receptor antagonists. In the meantime, the 1 3 activators of the delayed preconditioning response. potential attraction of therapeutic A receptor agonist-3 triggered cardioprotection (early and late forms) lies in the apparent absence of vascular or cardiodynamic effects of 3 . Adenosine A receptor agonist-induced delayed A receptor agonists at cardioprotective doses. diated by A receptor activation, this has not been definireceptor activation has been documented in the rabbit [40] . 1 tively proven [37] . Moreover, studies in mice with knockThe animals were treated with a single intravenous bolus out of the A receptor gene, suggest that A receptor of CCPA 100 mg / kg or saline vehicle. After a period of 3 3 activation may have bipolar effects in myocardial is-24-96 h, the animals were subjected to index coronary chemia-reperfusion, exacerbates ischemic injury and plays artery occlusion and infarct size was assessed with TTC no role in the classic preconditioning response [38] . Of staining. CCPA treated animals had significantly smaller course, the interpretation of knock-out mouse studies can infarct size compared to saline treated controls at 24, 48 never be regarded as definitive. Deletion of a gene may and 72 h but no protection was observed at 96 h (Fig. 2D) . result in the induction of multiple compensatory changes
The time course of protection after CCPA treatment in this and in receptor knock-out mice, dissection of the physiomodel is identical to that of delayed cardioprotection logical role of a receptor may not be possible if there is a following preconditioning with ischemia [16] receptor activation as a trigger for the delayed protective unstable angina for example, are at high risk of death or response in myocardium. Takano et al. [39] have undermyocardial infarction following an unstable episode and taken a pharmacological and molecular characterisation of this risk is particularly high in the first 1-2 weeks [41] . adenosine receptor participation in delayed protection.
These patients may therefore benefit from pretreatment They reported that the A receptor agonist IB-MECA (100 with agents that trigger or augment myocardial precondi- 3 or 300 mg / kg), given to rabbits 24 h before coronary tioning over a period of several days or weeks and could artery occlusion, resulted in limitation of infarction, commaintain the myocardium in a protected state. parable to that seen with the A agonist, CCPA. The A Downey's group addressed the possibility of extending 1 2 A receptor agonist CGS21680 was ineffective (see Fig. 2C ). the duration of classic preconditioning by using a continuThe distal molecular mechanisms appear to differ for A ous, high-dose infusion of CCPA in a rabbit model of 1 and A receptor activation (see below). It should be infarction [42] . Rabbits treated with a 6-h infusion of CCPA showed a significant limitation of infarct size. strated. Notably, in pigs and rabbits, the delayed protection However, no protection was observed after a 72-h infusion afforded by ischemic preconditioning against myocardial of CCPA. These workers concluded that myocytes become stunning following a subsequent period of ischemia, was desensitised to the protective effects of CCPA with pronot abolished by pretreatment with non-selective adenosine longed exposure, and this tachyphylaxis also rendered the receptor antagonists 8-SPT and PD115199 [48, 49] or with heart refractory to the beneficial effects of ischemic the selective A agonist N-0861 [47] . Furthermore, tran-1 preconditioning. The regulation of adenosine receptors has sient adenosine A receptor activation with CCPA failed to 1 been studied in a number of different tissues and developelicit delayed preconditioning against stunning in a conment of tachyphylaxis to adenosine A receptor agonists is scious rabbit model [48] .
1 both time-and concentration-dependent [43, 44] . Thus, reducing the dosing frequency might reasonably be expected to delay or abolish the development of tachyphylax-6 . Signal transduction is. We hypothesised that maintenance of a preconditioned state might be possible without development of tolerance 6 .1. PKC and tyrosine kinases by exploiting the natural time course of delayed protection.
Rabbits were treated intermittently with repeated inThe intracellular signaling pathways mediating the travenous boluses of CCPA 100 mg / kg or saline at 48-h delayed protective effects of adenosine A receptor activa-1 intervals [45] . Forty eight hours after the fifth dose (day tion are not completely understood. Although there is some 10), the animals were subjected to index coronary artery similarity with the pathways identified for delayed isocclusion and infarct size determination. To examine if the chemic preconditioning, there are divergences that are rabbits had developed tachyphylaxis to adenosine A 1 unsurprising, given the more complex nature of an isreceptor activation, a subgroup of animals was treated with chemic trigger versus pharmacological A receptor activa-1 a further bolus of CCPA 100 mg / kg and the hemodynamic tion. Adenosine receptors couple to protein kinase C response was monitored for 10 min prior to processing of (PKC) isoenzymes via the diacylglycerol-phospholipase C the heart for infarct size evaluation. Intermittent dosing pathway [50] . PKC has been well established by pharmawith CCPA over 10 days resulted in a 42% relative cological, biochemical and proteomic interrogations to be reduction in infarct size compared to vehicle pretreatment, an obligatory mediator of delayed ischemic preconditionconfirming that repeated recruitment of the delayed protecing [8, [51] [52] [53] [54] [55] [56] . Extensive studies by Ping and colleagues tive mechanism at 48-h intervals did not result in a loss of have established the role of PKC-e and h isoenzymes, protection. Furthermore, application of CCPA after 10 days together with tyrosine kinases of the Src family, as of intermittent treatment resulted in unmodified hypotenobligatory signaling intermediates of ischemic precondision and bradycardia, with no evidence of functional tioning in rabbit myocardium [8, 55, 56] . Dana et al. [57] downregulation of A receptors. 1 showed that early inhibition of PKC with chelerythrine Travers et al. [46] reported similar experiences with chloride, or inhibition of tyrosine kinases with lavendustin GR79236, another selective A agonist. In rabbits, 1 A prior to CCPA, completely abolished the late infarct GR79236 induced delayed protection against infarction 24 limitation. Thus, one or more PKC isoenzymes and and 48 h after a single bolus treatment. Administration of tyrosine kinases play an essential role in mediating the GR79236 as a once-daily intravenous dose over a period of delayed protection against infarction induced by A re-1 7 days resulted in the maintenance of protection which was ceptor activation. The PKC isoenzymes activated by CCPA evident 24 h after the final dose [27] . These findings were not identified in this study. Because the early suggest that at least in the rabbit, the duration of delayed inhibition of either PKC or tyrosine kinases completely protection against infarction following pharmacological abolished the delayed protection induced by CCPA, it is preconditioning with CCPA can be extended to a minimum likely that the enzymes are activated sequentially rather of 10 days by intermittent dosing. than in parallel pathways. A role of early tyrosine kinase activation by CCPA is implicated in studies by Kukreja's group [58] in which treatment with genistein prior to 5 . Adenosine and delayed protection against CCPA abolished the delayed infarct limiting effect of myocardial stunning CCPA in murine myocardium.
Both A and A receptor activation independently 1 3 induce an acute attenuation of stunning in rabbit myocar-6 .2. p38 MAP kinase dium [47] . Although adenosine A receptor activation 1 robustly induces late protection against infarction in severAmong the mitogen-activated protein (MAP) kinase al species, and a functional correlate of infarction in the families, the role of stress-activated kinase, p38 MAP isolated rabbit heart [27] , protection against other endkinase, has received special attention in relation to A 1 points of ischemia-reperfusion injury has not been demonreceptor-induced delayed protection. Adenosine treatment of the isolated rat heart was observed to cause rapid 7 . Distal mediator(s) of A and A agonist-induced 1 3 phosphorylation of MAP kinase-activated protein kinase-2 delayed protection (MAPKAPK-2), a downstream substrate of p38 MAP kinase [59] . Dana et al. [57] observed that myocardial p38
The gradual onset and prolonged duration of protection MAP kinase catalytic activity was markedly elevated 24 h following ischemic preconditioning and adenosine agonistafter treatment with CCPA. This increase in p38 activity induced delayed protection are compatible with cellular correlated with phosphorylation of the small heat shock mechanisms involving the new synthesis and degradation protein HSP27 (see below). The time course of this p38 of cardioprotective protein(s). In the global context of MAP kinase induction is unknown as are the identity of delayed protection studies, several inducible proteins assothe active isoenzyme and the mechanisms of its regulation. ciated with late protection have been proposed. However, It is also unknown if this apparent increase in p38 MAP it is essential to emphasise that although pharmacological kinase activity is sustained throughout the period following A or A receptor activation fully recapitulates the late 1 3 A agonist stimulation until the period of protection 24-72 infarct-limiting effect of ischemic preconditioning, the 1 h later. If this is not the case, how this late increase in precise molecular mechanisms controlling this protection kinase activity occurred in the absence of any reinforcing may differ according to the nature of the triggering stimulus such as ischemia remains to be determined [60] .
stimulus. With this caveat, most workers believe that the Workers in Kukreja's laboratory [58] have reported that skeleton of the delayed preconditioning paradigm holds SB203580 given prior to CCPA abolished the late protectrue for pharmacological delayed protection, involving an tion afforded by CCPA in isolated mouse heart, suggesting upstream kinase cascade, transcriptional regulation of that early activation of p38 MAP kinase follows A target genes, and the accumulation and subsequent activa- ischaemia-reperfusion or other oxidative stresses [63, 64] . This enhanced phosphorylation of p38 MAP kinase was There has been interest in the potential of some of HSPs to correlated with protection against infarction because act as the effectors of delayed ischemic preconditioning. SB203580 and genistein given before CCPA, abolished Transfection [65] or transgenic overexpression [66] [67] [68] of protection and also blocked the phosphorylation of p38 HSP72 is associated with enhanced tissue tolerance to MAP kinase during the subsequent ischemia. A further ischemia-reperfusion injury. In the early report of delayed intriguing observation was that this late phosphorylation of preconditioning by Marber and colleagues [5], accumulap38 MAP kinase in CCPA-pretreated hearts was abolished tion of myocardial HSP72 occurred in preconditioned by 5-hydroxydecanoate (5-HD) given at the time of index hearts. While such associations are provocative, the availischaemia, suggesting that opening of the mitochondrial able evidence is consistent with HSP72 being a marker of K channel participates in the distal signaling mechathe cellular stress response but not an essential mediator of ATP nism. Evidence for a role of mitochondrial K in delayed ischemic preconditioning. The protein is not ATP adenosine-induced delayed protection is discussed in more induced by A receptor agonist treatment [40, 69] . 1 detail below. The small HSP family member, HSP27, is a major substrate for MAPKAPK-2, downstream of p38 MAP kinase. Phosphorylation of HSP27 has been suggested to 6 .3. Transcription play an important role in the regulation of actin microfilament dynamics [70, 71] . Furthermore, it has been demonSome important downstream elements of the signalling strated that overexpression of HSP27 in transfected adult cascade have been described for delayed ischemic precardiac myocytes resulted in enhanced resistance against conditioning and pharmacological preconditioning with ischemic injury [72] . Dana et al. examined the potential nitric oxide donors, including those impinging upon the role for HSP27 phosphorylation in mediating A agonist 1 activation of the key transcription factors nuclear factor-k induced delayed preconditioning [57] . Two-dimensional B and AP-1 [61, 62] . However, no studies to date have gel electrophoresis and Western blot analysis of rabbit reported or dissected any transcriptional mechanisms for myocardium pretreated 24 h previously with CCPA re-A agonist induced delayed protection.
vealed an acidic shift in HSP27, corresponding to an increase in mono-and bi-phosphorylated isoforms. FurMany studies point to important interactions between thermore, prior inhibition of either PKC or tyrosine kinase adenosine A receptor activation and the regulation of The mitochondrial antioxidant enzyme manganeseinduced late protection against infarction has been exsuperoxide dismutase (Mn-SOD) has been the subject of amined in three independent studies in rabbit myocardium considerable interest since the earliest reports of delayed [39, 69, 82] . In two studies it was observed that blockade of ischemic preconditioning. The experimental evidence for K channels with either glibenclamide or 5-HD prior to ATP involvement of Mn-SOD in preconditioning is reviewed index coronary occlusion abrogated the infarct-limiting by Masatsugu Hori in this issue (pp. 495-505). Hoshida et effect of CCPA pretreatment 24 h earlier [69, 82] . In the al. [73] reported that ischemic preconditioning of canine study by Takano et al. [39] , it was shown that the delayed myocardium induced a biphasic increase in Mn-SOD protection conferred by either A or A receptor activation 1 3 activity, with the later peak corresponding to the period of in rabbit myocardium was abrogated by 5-HD prior to the delayed protection. Yamashita et al. reported induction of index coronary occlusion. In a human-derived Girardi cell Mn-SOD induced by sublethal hypoxia [52] in neonatal model, examining responses to simulated ischemia, Carroll rat cardiomyocytes at a time point that paralleled the and Yellon demonstrated that exposure to adenosine appearance of delayed protection. Moreover, treatment enhanced cell viability following ischemia 24 h later with antisense oligonucleotides corresponding to the initia-(assessed by enzyme release and propidium iodide staintion site of Mn-SOD translation inhibited the increase in ing) [83] . The delayed protection induced by adenosine Mn-SOD content and activity, and abolished the increased was abolished when the pretreated cells were incubated tolerance to hypoxia 24 h after the preconditioning protowith 5-HD during the subsequent ischemic insult. col. Pharmacological induction of delayed preconditioning
The mechanism by which transient activation of A or N -(phenyl-2R-isopropyl)-adenosine (R-PIA) was found to
Moreover it is not clear how altered regulation of its upregulate several antioxidants acutely in rat cardiac opening characteristics occurs 24 h or more after adenosine myocytes over a 90-120- channel-related oxidant signalling in delayed protection abolished by pharmacological iNOS inhibition with two (see Fig. 3 ).
structurally distinct iNOS inhibitors [32] . However, in another study by Auchampach and colleagues using an 7 .4. Inducible nitric oxide synthase essentially similar pharmacological approach in rabbits, A 1 agonist induced delayed protection was found to be v An active area of controversy relates to the relationship inhibited by N -nitro-L-arginine a non-selective NOS between adenosine A receptor activation and subsequent inhibitor which would be expected to effectively inhibit all 1 induction of iNOS. There is compelling pharmacological NOS isoenzymes, including iNOS [39] . It is of special and genetic evidence that delayed preconditioning induced interest that in these workers' hands, A agonist induced 3 v by ischemia is dependent on the induction and activation late protection was not inhibited by N -nitro-L-arginine, of iNOS. This evidence is reviewed by Roberto Bolli implying a critical divergence in the distal mechanisms for elsewhere in this issue (pp. 506-519). However, there is A and A receptor-induced late protection. 1 3 no consensus that A -agonist induced delayed protection is 1 dependent on iNOS regulation. While one study showed 7 .5. Cyclo-oxygenase-2 that A agonist does not induce late protection in iNOS 1 knockout mice [86] , another study in the same mouse An intriguing focus of delayed preconditioning research in Bolli's laboratory during the last 2 years has been that the sub-acute cardioprotective action of A receptor 1 recognition of the induction of cyclo-oxygenase-2 (COXactivation is maintainable over a prolonged period provides 2). COX-2 inhibitors given prior to the index ischemic ground for optimism that pharmacological induction of insult in mice and rabbits abrogate the delayed protection delayed preconditioning myocardium may have therapeutic afforded by ischaemic preconditioning [88, 89] . Pharmacopotential. logical evidence suggests that NO from iNOS activates COX-2 through a cGMP-independent mechanism (Bolli, unpublished data reported at AHA Symposium, Seattle, A cknowledgements August 2001). It has been shown that neither A nor A 1 3 agonist induced delayed protection is contingent on upThe author gratefully acknowledges the Wellcome Trust regulation of COX-2 activity [90] . In view of the apparent and British Heart Foundation which have generously co-dependence and co-regulation of COX-2 and iNOS, the supported his work in this field. discord in the literature on iNOS upregulation following A requires emphasis. The relative contributions of these 1 two co-regulated mediators in adenosine-induced delayed R eferences protection remain unclear and require further exploration. Moreover, the COX-2 products and distal mechanism that and it is intriguing to speculate that, in relation to delayed to COX-2 activation. However, since adenosine-induced 
